Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Samsung Biologics reports third quarter 2023 financial results

    Oct 25, 2023, 09:02 AM by
    Incheon, S. Korea, October 25, 2023 – Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the third quarter of fiscal year 2023.
    Full story
  • 1upHealth Joins Early Adopter Program for NCQA Digital Content Services

    Oct 25, 2023, 09:02 AM by
    Full story
  • New Threat Actors Drive Record Levels of Ransomware Attacks in September

    Oct 25, 2023, 09:02 AM by
    A new research report from cybersecurity consulting firm, NCC Group finds healthcare experienced an 86% increase in ransomware attacks in September over August. Overall, there was a record high number of ransomware attacks launched by cybercriminals in September, with 514 victims -- a 153% year-on-year rise from September, 2022. This increase was accompanied by the emergence of new threat actors, such as LostTrust and RansomedVC, who became some of the most active groups.
    Full story
  • Proscia Achieves ISO 27001 Security Certification

    Oct 25, 2023, 09:02 AM by
    Compliance with global information security management standard strengthens customer trust
    Full story
  • Follow the Money: Generative AI, bioMérieux Expands Oxford Nanopore Investment, Radiopharmaceuticals Development, More

    Oct 25, 2023, 01:00 AM by User Not Found
    Bio-IT World | bioMérieux further invests in Oxford Nanopore’s in vitro diagnostics; Automata Technologies raises funds for lab automation; NVIDIA and others invest in Iambic Therapeutics (formerly Entos) for generative AI; and more.
    Full story
  • Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox

    Oct 24, 2023, 08:27 AM by
    Full story
  • Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma’s portfolio companies

    Oct 24, 2023, 08:27 AM by
    Full story
  • Creative Biostructure Announces Comprehensive Exosome Analysis Services

    Oct 24, 2023, 08:27 AM by
    Full story
  • Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach

    Oct 24, 2023, 08:27 AM by
    Full story
  • CD BioGlyco Releases One-Stop Services for Glycoprotein-Based Vaccine Development

    Oct 24, 2023, 08:27 AM by
    Full story
  • Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use

    Oct 24, 2023, 08:27 AM by
    Full story
  • Optibrium introduces cloud-based version of StarDrop drug discovery platform

    Oct 23, 2023, 08:52 AM by
    Optibrium introduces a cloud-based version of StarDrop, its drug discovery platform.
    Full story
  • Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology

    Oct 23, 2023, 08:51 AM by
    Full story
  • Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services

    Oct 23, 2023, 08:51 AM by
    Full story
  • Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry

    Oct 23, 2023, 08:51 AM by
    Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.
    Full story
  • Empowering Research Excellence: Alfa Chemistry's THEIC, D-Pantethine, and Methoxytriethyleneoxypropyltrimethoxysilane at the Forefront

    Oct 20, 2023, 08:55 AM by
    Full story
  • Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases

    Oct 20, 2023, 08:55 AM by
    Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Purespring Therapeutics, a biotech innovator company, to accelerate the manufacture of their gene therapies for the treatment of chronic renal diseases that are currently poorly addressed.
    Full story
  • A Shift Toward Multiomics: How Genome Sequencing is Improving Human Health

    Oct 20, 2023, 01:00 AM by User Not Found
    Bio-IT World| There has perhaps never been a more exciting time to work in genetics. Thanks to technological advances and information sharing through various industry and academic collaborations, we know more today about the human genome and how it influences human health than could have ever been previously imagined.
    Full story
  • Magritek opens up benchtop NMR to new reaction monitoring applications

    Oct 19, 2023, 09:05 AM by
    Full story
  • CD Formulation's Scientists Share A Holistic Approach on How to Prepare Drug Microcapsules

    Oct 19, 2023, 09:05 AM by
    Full story
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68 (current)
  • 69
  • 70
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy